News
1h
Study Finds on MSNExperimental Drug Pairing Offers Hope For Aggressive Ovarian CancerIn A Nutshell High-throughput drug screening identified rigosertib as highly selective for ovarian cancer cells. Alone, rigosertib shuts down one survival pathway but triggers compensatory activation ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Forensic toxicologist Okorie Okorocha said the presence of drugs doesn't automatically mean an overdose was the cause of death.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results